Home > Boards > US Listed > Medical - Drugs > Onconova Therapeutics (ONTX)

Dilution news.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
willlbone Member Profile
 
Followed By 74
Posts 5,785
Boards Moderated 0
Alias Born 06/28/07
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 1/17/2020 5:26:51 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/13/2020 4:07:50 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/10/2020 4:04:19 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/3/2020 5:30:36 PM
Onconova Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market... GlobeNewswire Inc. - 1/3/2020 1:27:41 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/3/2020 9:29:13 AM
Onconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-Market GlobeNewswire Inc. - 12/31/2019 11:30:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/19/2019 4:51:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/19/2019 4:17:54 PM
Onconova Therapeutics, Inc. Announces Closing Of $5.0 Million Registered Direct Offering Priced At-The-Market GlobeNewswire Inc. - 12/19/2019 1:44:55 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/19/2019 9:23:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/19/2019 9:20:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/19/2019 9:07:59 AM
Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 12/18/2019 9:05:10 AM
Onconova Therapeutics Announces Exclusive License Agreement with Specialised Therapeutics for Rigosertib in Australia and New... GlobeNewswire Inc. - 12/18/2019 9:00:10 AM
Onconova Therapeutics and Pint Pharma Announce Brazilian Health Authority Approval for Initiating INSPIRE Trial with Intraven... GlobeNewswire Inc. - 12/17/2019 7:30:10 AM
Onconova Therapeutics, Inc. Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 12/10/2019 3:07:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/10/2019 11:20:38 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 12/10/2019 8:02:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/9/2019 9:08:20 AM
Onconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azac... GlobeNewswire Inc. - 12/9/2019 9:00:10 AM
Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market GlobeNewswire Inc. - 12/9/2019 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2019 4:06:30 PM
Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Cou... GlobeNewswire Inc. - 12/6/2019 7:30:10 AM
Eco Allies (OTC Pink: SVSN) Progresses on $90 million NYSE Listed Hemp REIT InvestorsHub NewsWire - 12/3/2019 6:00:00 AM
willlbone   Monday, 09/23/19 09:54:18 AM
Re: None
Post # of 2085 
Dilution news.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist